<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Testosterone therapy is commonly utilized to treat hypogonadism. After diagnosis with morning serum testosterone level in patients with symptoms of hypogonadism, therapy has been shown to improve symptoms. Research focusing on cardiovascular risks associated with testosterone therapy has produced contradictory statements. We review trials that have investigated the impact of testosterone supplementation on heart failure, coronary artery disease, and myocardial ischemia.</p>
</abstract>

Testosterone therapy is commonly utilized to treat hypogonadism. After diagnosis with morning serum testosterone level in patients with symptoms of hypogonadism, therapy has been shown to improve symptoms. Research focusing on cardiovascular risks associated with testosterone therapy has produced contradictory statements. We review trials that have investigated the impact of testosterone supplementation on heart failure, coronary artery disease, and myocardial ischemia.

A review of testosterone supplementation and cardiovascular risk

Romanian Journal of Internal Medicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

{"article-title":"A review of testosterone supplementation and cardiovascular risk"}

Testosterone therapy is commonly utilized to treat hypogonadism. After diagnosis with morning serum testosterone level in patients with symptoms of...

A review of testosterone supplementation and cardiovascular risk

Online veröffentlicht: 16. März 2023

Seitenbereich: 35 - 40

Eingereicht: 17. Nov. 2022

DOI: https://doi.org/10.2478/rjim-2022-0022

Schlüsselwörter
testosterone, supplementation, cardiovascular risk

© 2023 Nikita Jhawar et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

A review of testosterone supplementation and cardiovascular risk

Online veröffentlicht: 16. März 2023

Seitenbereich: 35 - 40

Eingereicht: 17. Nov. 2022

DOI: https://doi.org/10.2478/rjim-2022-0022

Schlüsselwörtertestosterone, supplementation, cardiovascular risk

© 2023 Nikita Jhawar et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Schlüsselwörter
testosterone, supplementation, cardiovascular risk